chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3/30/07 fever 103 rectal; continues as low grad as of 4/2/07. 3/31/07 light cough and runny nose; cough progressing. 4/1/07 rash - lower abd and back.
Onset: 9/18 vaccine site L arm: itching. 9/20 appears as 2" X 1" redness with 1/8" maroon center. Onset: 9/18 headache, fatigue. 9/19/vesicles on forearm, R thigh, stomach (abdomen), back, R hand vesicles are itchy. (9/20-feels better).
Pt developed nausea and vomiting approximately 24 hours after each Anthrax shot.
muscle in right leg and bottom foot hurt her for and on achy almost like slight Muscle cramp and felt weakness; muscle in right leg and bottom foot hurt her for and on achy almost like slight Muscle cramp and felt weakness; muscle in right leg and bottom foot hurt her for and on achy almost like slight Muscle cramp and felt weakness; right big toe and index felt burning on and off for days/Feel burning but those toes once in a while; Still have right leg pain on calf and under knee and upper leg; This is a spontaneous report from a non-contactable consumer. A 50-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: Ew0150), via an unspecified route of administration on 11Apr2021 at 09:45 (at the age of 50-year-old), as dose 2, single in left arm for COVID-19 immunization at hospital. The patient's medical history included migraine and had allergies for penicillin. Concomitant medications within 2 weeks of vaccination included magnesium, ibuprofen (ADVIL 12 HOUR), atorvastatin one pill; all taken for unspecified indications, start and stop dates were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: Ep7534), via unspecified route of administration on 21Mar2021 at 09:45 (at the age of 50-year-old), as single dose in left leg for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Apr2021 at 08:00, after the administration of second dose of vaccine, the patient muscle in right leg and bottom foot hurt her for and on achy almost like slight muscle cramp and felt weakness. Third day same with leg and right arm. Fourth day felt muscle pain but not weakness, but right big toe and index felt burning on and off for days. The patient reported that months later now it was July and still had right leg pain on calf and under knee and upper leg. The patient felt burning but those toes once in a while. Adverse event result in Emergency Room visit. Patient had Doppler Ultrasound as treatment for the events. The patient underwent lab tets and procedures which included SARS-CoV-2 test (nasal swab): negative on 11May2021. The patient had COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all the events was not resolved.   No follow-up attempts are possible. No further information is expected.
Local erythema, edema, muscle aches, paresthesia, arthralgia, headaches.
Patient had redness in the area that was administered. The redness has spread since that date of administration and area is swollen.
Vaccine was stored in a household style freezer without a DDL thermometer (a non-approved thermometer was used instead to record the freezer temperature).  In my professional opinion(pharmacist), there was no temperature excursion at any point for when we received the vaccine it was completely frozen, it stayed completely frozen and was then transferred to an approved refrigerator with a DDL thermometer where it was thawed and given to the patient.  However, just to follow protocol, we did reach out to the patients and informed them of what happened and advised that they can get another booster shot if they wanted to.  We also reported to Moderna per protocol along with VAERS.
all 4 pt describe severe achiness & malaise beginning 2-3 days p/vax;sx lasting 2 wk;no other sx;
Developed 3 1/2" X 4" red papular rash over injection site on 2/23/02 and evolved into 6 to 12 vesicles; several on chest and 1 on face.
Patient received pediatric dose of  Pfizer Covid-19 vaccine, no reactions, symptoms etc.  Per our pharmacy department, requires a VAERS report related to an errors re:  COVID -19 vaccines.
pt recv vax 27OCT98 & 29OCT98 reported aches across chest & shoulders, head feels cloudy, runny nose, faint feeling;states breathing is an effort & describes it as heavy breathing;taken to ER;T100 x 4 days;
Pt. complained of chest pain (left side) that lasted a couple of seconds.  Vitals: OxSat 98%, HR 93, BP132/84, @ 0930, 130/78 @ 9041.  Pt monitored for additional 15 min.  States she felt ok, and returned to work.
pt recvd vax 4JUN94 & 5JUN94 pt cried all day & low grade fever; crying & temp persists 6JUN94; no leg swelling, redness, hardness; dec appetite 5 & 6JUN;
Hep B dose number 2 was given too soon from the date of the first dose.  The first dose was given on 12/5/22.  The second dose should have been given 4-6 weeks later.
Information has been received from a physician concerning a 52 year old female with no pertinent medical history, drug reaction/allergies, who on 28-FEB-2011 was vaccinated with the second dose of VARIVAX (Merck) (Lot number not provided). In March 2011 (day unknown), the patient developed a rash and nerve pain in her arm with the rash. No lab diagnostics studies were performed. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
Swelling with firmness and warmth 4.5cm x 5.5cm to right arm.
Began complaining of chest pressure, then reporters feeling tired and desires to lay down. Suddenly fell off the doctors table and fainted landing face down and injuring the left side of his head and right calf.
Information has been received from a consumer concerning a female who was vaccinated with varicella virus vaccine live. Subsequently, the pt developed chickenpox. No further details were provided. Unspecified medical attention was sought. Additional information has been requested.
Case number PHEH2014US025026, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 83-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 12 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
In retrospective chart review it was determined that the patient received the Janssen vaccine at age 17.  Currently authorized for 18 years of age and older.
Within 24 hours, post vax, developed pain, swelling and erythema at site of injection (DTAP). The 2nd 24 hours, the symptoms worsened to involve the entire thigh. No infection. No systemic symptoms. No fever.
Client reported itching that started on 01/15/16 at around 5PM. Per mom, client described the itching as all over his body. When scratched, his skin erupted in small blisters that did not ooze, but according to client looked like they could erupt if he continued scratching. Per mom, client refrained from scratching for this reason. Mom stated client was given Benadryl since the itching started and that seemed to help his symptoms. Client went to primary care provider on 01/20/15 and was told by physician he believed this to be a reaction to the vaccine administered and gave him prednisone to reduce itching and swelling. Physician recommended not continuing the HPV series. Mom stated she noticed today that client's face and neck are swollen, and that she can see this "swelling underneath his chin". Mom also disclosed that client had felt a "lump" under his collarbone after his first set of vaccines on 11/09/15, but his physician believed this lump to not be related to the immunizations. Mom stated client denies any shortness of breath, difficulty swallowing or speaking, tingling in the lips/mouth, or swelling of the tongue. Client did tell mom the "inside of his mouth feels rough."
All over pain, chills, temperature, sweating, headache, just felt sick all over all night. Next day I am some better but still have chill, muscle pain, and feel sick all over.
Red raised bumps around the injection site where I received my 2nd shot on my right arm and hives on on my forearm on my right arm hives were also red and itchy. It lasted about two to three days. I treated it with an anti-itch cream and also Tylenol because I was extremely tired.
Actually had  2 adverse events, #1 on the night of the vaccine.had terrible heartburn,which i never get,that started in my sleep ,and literally woke me up in the middle of the night.Also alot of gas and burping. Lasted about a day. # Midweek,as I  reported. about the wed after receiving  first dose friday AM,  I started having dry mouth and extremely dry lips, and  continuous thirst. Didnt have to drink much, but continued recurring over the course of  one and a half to 2 weeks, until finally disappeared. I was advised by one of my physicians to put real lemon juice on tip of tongue to stimulate the salivary glands.That really helped. did hear that this happened to several other patients.
Patient mother called to detailed events that had happened to her daughter. She made clear her baby started having unfamiliar symptoms  after the first dose  of Pfizer vaccine, however, they could not confirm the cause was the vaccine. She further indicated that her illness got worse after the second dose.  She indicated that her daughter started showing signs of weakness in the arms, legs and and   whole body from the first dose. She made mention that, the illness progressed to face, lungs and heart and baby has not recovered ever since she received the second dose. She added, they just got confirmation from a hospital the vaccine was the cause of her daughter neurological illness.   She did not indicates treatment her baby is receiving, just want to report to the pharmacy where the vaccine was giving.
Information has been received from a pharmacist concerning a male physician who on 12-NOV-2007 was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot# 657039/0698U). On approximately 12-NOV-2007, within 24 hours of receiving the vaccine, the patient developed cellulitis, pain, swelling, fever and was reported to have been treated with multiple antibiotics due to streaking on the skin. It was unknown if the patient recovered. It was reported that this patient may be a liver failure patient. Additional information has been requested.
While driving home from obtaining the vaccine (1 hour later), patient called to say her face " felt funny, possibly swollen" I advised to got to the ER.  Patient went to ER and received prednisone and benadyl
Rash and hives on entire face - took Benadryl, but that did not help Around 1:00 AM on 6/1/2021 - went to Emergency Room - lips were tingling and throat was closing up They gave me dexamethasone sodium phosphate injection 10 mg & famotidine 20 mg Rash cleared up on 6/3/2021 My known allergies are allopurinol and iodinated contrast media - IV dye
Per patient, around 10 am she received her Pfizer shot. During her 15 min observation period (after the shot while), she sat in the pharmacy area. She started to feel tingling in her calf, so she moved around and felt better. Around dinnertime, she felt as if something was biting her legs, so she removed her tights (she thought they were too tight). After removing the tights, her legs felt needle-like biting, which also spread to her arms. She said her skin is fine. No bumps, hives or redness. Recommended following-up with physician.
admitted for increased work of breathing with hypoxemia to 88% in the setting of a positive COVID rapid antigen test. Her symptoms began 4/25 with positive test on 4/26. Fully vaccinated x3. CXR showed hypoinflated with bronchovascular crowding and hazy bilateral airspace opacities consistent with infection. She follows with pulmonology and is on airway clearance protocol with chest physiotherapy, cough assist, and albuterol twice daily which is increased to 4 times daily during infection.
I was monitored for 15 minutes and felt completely fine and left the location. On my way home approximately 25 minutes after my vaccination I felt a tingling and numbness in the back of my throat. I decided to call the center and let them know how I was feeling. They suggested I return. During the 10 minute ride back the tingling and numbness had progressed to the back of my tongue. Once I arrived there they continued to monitor me and my symptoms remained stable with numbness in my throat and back of my tongue. I was not having any difficulty breathing and felt otherwise fine. There was a concern that the symptoms would progress and they initiated EMS. I was taken via ambulance to Hospital where they continued to monitor me and check my airway.. In route to the hospital I was hypertensive with a BP of approx 190/100. I did not ask what my heart rate was. I was surprised my blood pressure was so high. They said it was probably because I was nervous however I was not feeling nervous because I knew since I could breathe I really was fine, and sending me to the hospital was simply out of an abundance of caution as this vaccine is new. Upon my arrival they took my blood pressure again and it was 140s/80s I believe with a heart rate of 106. My O2 sat we?re in the upper 90?s throughout the situation. My blood pressure tends to be in the 110s/70s with a heart rate in the upper 60s to mid 70s. So it was surprising to me that I was hypertensive and tachycardic despite not feeling like my heart was racing or that my blood pressure was high. I felt completely fine other than the numbness in the back of my throat and tongue. Since the symptoms remained stable and there wasn?t really anything for anybody to do they did release me. Between 6:30 and 7 PM I noticed the tongue numbness was subsiding. By 8 PM my throat felt completely back to normal.
1/9/03 Mom called to report swelling and sl. redness R upper arm. Rec'd DTaP, IPV R arm on 1/8/03. To give Tylenol and cool compresses prn. Will come tomorrow to tricep. 1/10/03 4x3.5 cm swelling and sl. redness to R upper outer arm. Mom says more comfortable with Tylenol and cool compresses. 1/21/03 spoke mom on another matter. States swelling gone by next day 1/11/03.
After the second dose of study drug on 06/26/2008, the subject had a recurrence of the AE tinnitus on 06/26/2008 (there is no grade 1 tinnitus on the CTCAE.)  The subject stated that this second episode of tinnitus was much milder than the previously reported episode that had resolved on 05/13/2008.  The patient had discussed his tinnitus and the vaccine study with his physician on 5/22/08.  The subject felt strongly that he wanted to continue on study.  This 06/26/2008 episode resolved fully without treatment on 07/09/2008.
fever; rash all over her body; muscle pains; Extra dose administered; First dose / on July2018, second dose on Dec2018 / third dose was given on Feb2019 / fourth dose on 08Mar2021; This case was reported by a pharmacist via and described the occurrence of muscle pain in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in July 2018) and Shingrix (received 2nd dose in December 2018).   On 8th March 2021, the patient received the 4th dose of Shingrix (intramuscular). On 1st February 2019, the patient received the 3rd dose of Shingrix (intramuscular). On 1st February 2019, not applicable after receiving Shingrix and unknown after receiving Shingrix, the patient experienced extra dose administered. On 8th March 2021, the patient experienced muscle pain, extra dose administered and drug dose administration interval too long. On 9th March 2021, the patient experienced rash. On an unknown date, the patient experienced fever. The patient was treated with prednisone, paracetamol (Tylenol) and hydroxyzine. On an unknown date, the outcome of the muscle pain, rash, fever, extra dose administered, extra dose administered and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the muscle pain, rash and fever to be related to Shingrix.  Additional details were provided as follows: The patient received 3rd dose of Shingrix, which led to extra dose administered. The patient received 4th dose of Shingrix and on same day experienced fever and muscle pain. The next day, patient experienced rash. The patient received 4th dose of Shingrix, which led to extra dose administered. The reporter consented to follow up.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 28-JUL-2014 the patient was vaccinated with 0.5ml dose of (oka/MERCK) VARIVAX, subcutaneous (lot#, strength and frequency unspecified) and 0.5ml dose of (oka/MERCK) PROQUAD (lot#, strength, route and frequency unspecified) inadvertently. No adverse effects reported. Additional information has been requested.
On day of injection and next day, I had a  sore arm and slight fatigue, no other symptoms. One week (day 7) after injection, found swollen lymph node under left arm. On day 8, found itchy pink raised spot (like a large mosquito bite) about 1/2 inch long, not at exact injection site but maybe 2 inches below site. On day 9 (today), I have a raised pink rash on upper left arm ranging from injection site to the previous raised itchy site (about 3 inches). I have no other symptoms and feel fine.
Suspected vaccination failure/ influenza three times. First time was when I had a flu shot; influenza three times. First time was when I had a flu shot; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   The patient's past medical history included rubella, mumps and chickenpox.   On an unknown date, the patient received the 1st dose of Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the influenza was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were reported as follows: The patient's demographics were not reported. The patient stated that he/she had rubella, mumps and chicken pox. No vaccines were received. The patient also had influenza three times. The patient had 1st time influenza when he/she received flu shot and it too months to get over. The last two no flu shot was over in about a week. The patient not had it in a few years. No other information was reported. This case was considered as suspected vaccination failure as details regarding vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
chills; nausea; vomiting; severe tiredness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (severe tiredness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination.     The patient's past medical history included Suspected COVID-19 in March 2020. Family history included Immunocompromised (Family history of immunocompromised) since an unknown date.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (severe tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (severe tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
tested positive for COVID; tested positive for COVID; This is a spontaneous report from a Pfizer sponsored programme, from a non-contactable consumer (patient, self-reported). A female patient of an unspecified age, received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not reported), via an unspecified route of administration, on an unspecified date, as single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date, as single dose for COVID-19 immunization. It was reported that patient had both doses and tested positive for COVID in SARS-CoV-2 test. Patient asked that would like to know if she can get the vaccine again. Outcome of the event was unknown.  Additional information has been requested.; Sender's Comments: Based on the information currently available, lack of efficacy of the vaccine BNT162B2 cannot be completely excluded. However, information provided is limited and does not allow for a complete medical assessment. Case will be  reassessed if additional information is received
STOMACH CRAMPING; DIARRHEA; NAUSEA; LOSS OF APPETITE; This spontaneous report received from a patient concerned a 54 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 8351698, and batch number: 8351698 expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced loss of appetite. On 16-APR-2021, the subject experienced stomach cramping. On 16-APR-2021, the subject experienced diarrhea. On 16-APR-2021, the subject experienced nausea. Treatment medications (dates unspecified) included: loperamide hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from loss of appetite, nausea, stomach cramping, and diarrhea. This report was non-serious.
This spontaneous report was received from a physician via a company representative and refers to a 12 year old non-pregnant female patient. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were unknown. On an unknown date, the patient was intramuscularly vaccinated with the first dose of GARDASIL 9 (site of administration, dose, lot number and expiration date were not reported). On an unknown date, "while on" GARDASIL 9, the patient developed hives. The patient sought medical attention via a physician visit. It was unknown if any lab diagnostic studies were performed. No treatment was given for the event. Product quality complaint was not involved. The GARDASIL 9 vaccination series was not discontinued. The outcome of developing hives and the relatedness between this event and the vaccination with GARDASIL 9 were not reported. Additional information has been requested.
Large red circle around the injection site.  Feels warm the touch.  3"W x 2.5"H   red circle around injection site and hard lump in the middle.  Very painful to touch
Allergic reaction with urticaria, wheezing. Improved after benadryl, pepcid, decadron